Search
Showing results for "1"
Research
Insulin Pump Therapy in Adolescents With Very Poor Glycemic Control During a 12-Month Cohort TrialWe conclude that insulin pump therapy can be an effective tool to improve glycemic control in adolescents with long-standing treatment resistance
Research
Respiratory viral infections and host responses; insights from genomicsReview of the viral sensing pathways and organizing principles that govern the innate immune response to infection
News & Events
Congrats Dr Sabrina BinkowskiCongratulations to Dr Sabrina Binkowski from Rio Tinto Children's Diabetes Centre, who was awarded the ANZSPED research grant award of $20,000, at
News & Events
Dexcom G6 Early Access Program UpdateThe Dexcom G6 Early Access Program has so far been a huge success. The program commenced in May, and offered early access to the Dexcom G6 system to eligible patients.
News & Events
Do you have the power?Volunteers are needed for the upcoming camp for 11 and 12-year-olds living with Type 1 Diabetes.
News & Events
Smartphone donationsThe Diabetes Research Team is requesting donations of old iPhones for a new study investigating the effect of real time CGM on every day diabetes management.
News & Events
Low Carbohydrate DietsCarbohydrate restriction is used by some individuals with type 1 diabetes to reduce glucose excursions after eating a meal.
Research
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086Assessment of the persistence of bactericidal antibodies up to 4 years after a three-dose schedule of bivalent rLP2086
The Children's Diabetes Centre's research into Type 1 diabetes, childhood onset Type 2 diabetes and obesity aims to improve the lives of children and adolescents affected by these conditions.
Research
A phase 3, randomized, double-blinded, placebo-controlled trial toevaluate the efficacy and safety of a respiratory syncytial virus (RSV) prefusion F subunit vaccine in infants born to women vaccinated during pregnancy (Matisse)Peter Richmond MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials Group